MedPath

Personalised risk information and its impact on informed choice and intention to undergo colonoscopy in the Scottish Bowel Screening Programme

Not Applicable
Completed
Conditions
Colorectal cancer screening
Cancer
Registration Number
ISRCTN14254582
Lead Sponsor
Co-Sponsorship from University of Dundee and NHS Tayside
Brief Summary

2019 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/30991987 2020 results in https://pubmed.ncbi.nlm.nih.gov/33076932/ (added 22/10/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
308
Inclusion Criteria

Any adult registered on the Scottish Bowel Screening database aged 50-74.

Exclusion Criteria

Being currently treated for cancer.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Intention to take up the offer of colonoscopy, as a proxy for behaviour, will be measured on a Likert-type scale from 1 (low intention) to 7 (strongly intend) at a single time point on return of the study questionnaire<br> 2. Informed choice in cancer screening is measured uinsg a questionnaire adapted from a Smith et al measure at a single time point on return of the study questionnaire<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. Participants feeling informed about their decisions is measured using the Decisional Conflict Scale, Informed Choice subscale (3 items) at a single time point on return of the study questionnaire<br> 2. Anxiety is measured using the State Trait Anxiety Inventory at a single time point on return of the study questionnaire<br> 3. Ease of understanding and acceptability of the presentation of risk information measured using in the questionnaire using Likert-type questions scored on a 7-point scale from strongly agree” to strongly disagree at a single time point on return of the study questionnaire<br>
© Copyright 2025. All Rights Reserved by MedPath